House Republicans Challenge FDA On Warning Letter Appeals Process
Executive Summary
Senior House Republicans are challenging FDA on the fairness of its warning letter appeals process
You may also be interested in...
House Republicans Press FDA On Warning Letter Appeals
FDA leadership needs to review the agency's enforcement dispute resolution process, leading Republicans on the House Energy and Commerce Committee assert
FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.